Identification of circulating proteins from human plasma binding to oxidized phospholipids using pull-down proteomics. Enrichment of plasma proteins using OxPAPC and PAPC containing biotynilated liposomes. Identification of plasma proteins that inactivate toxic action of OxPLs.